Skip to main navigation Skip to search Skip to main content

£ Identification of a first-of-a-kind, small molecule, specific, USP18 inhibitor

Project Details

StatusFinished
Effective start/end date1/06/22 → 31/03/24

Funding

  • Bristol-Myers Squibb: £530,579.00